Corvus Pharmaceuticals to present at Guggenheim Healthcare Innovation Conference.

Corvus Pharmaceuticals announced that its leadership team will participate in a fireside chat and one-on-one meetings at the Guggenheim 2nd Annual Healthcare Innovation Conference in Boston, MA. The event is scheduled for November 10, 2025, and a webcast will be available on the company's website for 90 days following the event. Corvus is a clinical-stage biopharmaceutical company developing immunotherapy treatments for cancer and immune diseases, with its lead product candidate being soquelitinib, an investigational drug that selectively inhibits the protein ITK.